Mankind Cefastar CV 200 mg Tablet (Cefpodoxime Proxetil & Clavulanic Acid) for Dogs and Cats

Product Type: Veterinary antibiotic tablet
Active Ingredients:

• Cefpodoxime Proxetil – 200 mg

• Clavulanic Acid – 125 mg

Suitable For: Dogs and cats

Indications / Uses

Mankind Cefastar CV 200 mg may be used under veterinary direction for susceptible bacterial infections such as:

• Respiratory tract infections

• Skin and soft tissue infections

• Urinary tract infections

• Other bacterial infections that are susceptible to the combination

Antibacterial Action

Cefpodoxime Proxetil acts by interfering with the process bacteria require to form and maintain their cell walls. Clavulanic acid is included to help inhibit certain bacterial resistance mechanisms, allowing cefpodoxime to remain active against susceptible bacteria that may otherwise produce resistance-related enzymes.

Directions for Use

Administer the tablet orally according to the dosage and schedule prescribed by the veterinarian. Based on the supplied product information, it may be administered with or without food. Maintaining a consistent administration time can help keep the treatment routine regular.

The required dosage regimen should be determined by the veterinarian according to the animal's body weight, type and location of infection, clinical condition, and treatment response. The supplied information does not provide a specific weight-based dosing table, so a dose should not be calculated from the tablet strength alone.

When an antibiotic course is prescribed, administer it for the complete duration advised by the veterinarian even when clinical signs improve earlier. Premature discontinuation or inappropriate antibiotic use may result in inadequate treatment and can contribute to antimicrobial resistance.

Veterinary Use and Precautions

This product is intended for dogs and cats and should be used under appropriate veterinary supervision. The supplied information does not specify detailed contraindications, adverse reactions, drug interactions, or a fixed treatment duration. These details should therefore be confirmed from the current product packaging and the prescribing veterinarian before use.